In the present study, we aimed to investigate the effects of Artemisia argyi essential oil（AO） on pulmonary hypertension（PH） induced by monocrotaline（MCT） and to explore the underlying mechanism. A total of 80 S...In the present study, we aimed to investigate the effects of Artemisia argyi essential oil（AO） on pulmonary hypertension（PH） induced by monocrotaline（MCT） and to explore the underlying mechanism. A total of 80 Sprague-Dawley rats were randomly divided into four groups as follows： control group, model group, bosentan（0.1 g/kg） group and AO（0.1 g/kg） group. After 30 d of experiment, hemodynamic parameters, lung and right ventricle hypertrophy index were determined. HE and Immunohistochemistry staining of lungs were performed to detect the injuries and protein expressions. The results showed that levels of m PAP, m RVP, max RVP, w W, LI, RV and RVHI as well as the expressions of NF-κB p65 and α-SMA were increased, small pulmonary artery thickened, the cavity of the arteriole narrowed, and there was marked infiltration of inflammatory cells in lungs of rats receiving MCT compared with the normal group. After the administration of AO, the levels of m PAP and m RVP were significantly decreased, and the w W, LI, LV＋S and pulmonary arterial remodeling were markedly improved. The expression levels of NF-κB p65 and α-SMA were reduced by AO compared with the model group. Our results suggested that AO reduced the progression of PH induced by MCT through inhibiting the expressions of NF-κB p65 and α-SMA.展开更多
基金The Natural Science Foundation of Zhejiang Province of China(Grant No.LQ14H280003)the TCM Project of Zhejiang Province(Grant No.2011ZA006)+2 种基金the Chinese Integrative Medicine Foundation of Zhejiang Province(Grant No.2013LYSX020)Zhejiang Provincial Program for the Cultivation of High-level Innovative Heath Talents(Ping Huang)Zhejiang 151 Elites Project,the second level(Ping Huang)
文摘In the present study, we aimed to investigate the effects of Artemisia argyi essential oil（AO） on pulmonary hypertension（PH） induced by monocrotaline（MCT） and to explore the underlying mechanism. A total of 80 Sprague-Dawley rats were randomly divided into four groups as follows： control group, model group, bosentan（0.1 g/kg） group and AO（0.1 g/kg） group. After 30 d of experiment, hemodynamic parameters, lung and right ventricle hypertrophy index were determined. HE and Immunohistochemistry staining of lungs were performed to detect the injuries and protein expressions. The results showed that levels of m PAP, m RVP, max RVP, w W, LI, RV and RVHI as well as the expressions of NF-κB p65 and α-SMA were increased, small pulmonary artery thickened, the cavity of the arteriole narrowed, and there was marked infiltration of inflammatory cells in lungs of rats receiving MCT compared with the normal group. After the administration of AO, the levels of m PAP and m RVP were significantly decreased, and the w W, LI, LV＋S and pulmonary arterial remodeling were markedly improved. The expression levels of NF-κB p65 and α-SMA were reduced by AO compared with the model group. Our results suggested that AO reduced the progression of PH induced by MCT through inhibiting the expressions of NF-κB p65 and α-SMA.
